BOLT

Bolt Biotherapeutics, Inc. Common Stock

6.30

USD

-0.13

-2.02%

Nov 10, 15:58 UTC -5

Closed

After-Market

6.28

-0.02

-0.40%

Bolt Biotherapeutics, Inc. Common Stock (BOLT) Profile

Bolt Biotherapeutics, Inc. Common Stock Profile

About

Bolt Biotherapeutics Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company's pipeline reflects biology and cancer drug development. Its lead program includes BDC-4182. Bolt Biotherapeutics Inc., formerly known as BOLT THERAPT, is based in REDWOOD CITY, Calif.

Info & Links

CEO

William P. Quinn

Headquarters

900 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

Bolt Biotherapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

14.79M

Enterprise Value

20.26M

Enterprise Value/EBITDA(ttm)

-0.67

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.68

Price to Book(mrq)

0.99

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-611.47%

Profit Margin(ttm)

-45714.04%

Return on Equity(ttm)

-126.23%

Return on Invested Capital(ttm)

-70.96%

Return on Assets(ttm)

-54.70%

Income Statement

Revenue(ttm)

4.70M

Revenue Per Share(ttm)

2.44

Gross Profit(ttm)

4.70M

EBITDA(ttm)³

-30.26M

Net Income Available to Common(ttm)

-28.74M

Diluted EPS(ttm)

-16.44

Share Statistics

Beta (5Y Monthly)

0.85

52-Week Change

38.46%

S&P 500 52-Week Change

16.62%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

1.93M

Dividend Yield

0.00%

Float⁴

1.75M

% Held by Insiders

9.40%

% Held by Institutions

86.70%

Balance Sheet

Total Cash(mrq)

17.80M

Total Cash Per Share(mrq)

9.24

Total Debt(mrq)

18.53M

Total Debt/Equity(mrq)

146.62%

Current Ratio(mrq)

2.61%

Quick Ratio(mrq)

2.61%

Book Value Per Share(mrq)

6.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-8.61

Free Cash Flow(ytd)

-13.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.